Skip to main content

Table 2 Characteristics of the acute COVID-19 in patients undergoing bronchoscopy in the post-acute phase

From: Bronchoscopy in the post-acute phase of COVID-19: an observational study

Median (IQR) hospital length of stay, days (n = 30)

53.5 (32–81)

Severity of acute infection

(WHO definition)

Mild

13 (29.6)

Moderate

6 (13.6)

Severe

6 (13.6)

Critical

19 (43.2)

Max ventilatory support

Room air

11 (24.4)

Supplemental oxygen

8 (17.8)

HFNC

3 (6.7)

CPAP

4 (8.9)

NIV

2 (4.4)

Tracheal intubation + invasive mechanical ventilation

17 (37.8)

Type of bronchoscope

Flexible

16 (69.6)

Flexible bronchoscope through tracheal tube

7 (30.4)

Indications

Suspected COVID-19

3 (13.0)

Haemoptysis

2 (8.7)

Suspected tracheal stenosis

3 (13.0)

Obstructive atelectasis

3 (13.0)

Management of tracheostomy complication (granuloma)

1 (4.3)

Decannulation

11 (47.8)

  1. WHO: World Health Organization; HFNC: high flow nasal cannula; CPAP: continuous positive airway pressure; NIV: non-invasive ventilation; COVID-19: coronavirus disease- 2019; IQR: interquartile range